Clinical trials
Active, not recruiting Diabetes Mellitus, Type 2 trials with no applicable phase
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
152 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 6 |
| 2019 | 5 |
| 2020 | 5 |
| 2021 | 13 |
| 2022 | 18 |
| 2023 | 20 |
| 2024 | 38 |
| 2025 | 29 |
| 2026 | 10 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Active, not recruiting | 152 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| State University of New York at Buffalo | 4 |
| University of North Carolina, Chapel Hill | 4 |
| Kaiser Permanente | 3 |
| University of British Columbia | 3 |
| University of Pittsburgh | 3 |
| AdventHealth Translational Research Institute | 2 |
| Aqua Medical, Inc. | 2 |
| Colorado State University | 2 |
| GT Metabolic Solutions, Inc. | 2 |
| Northwestern University | 2 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 152 |
| Obesity | 28 |
| Diabetes Mellitus | 20 |
| Hypertension | 13 |
| Insulin Resistance | 11 |
| Overweight | 9 |
| Prediabetic State | 8 |
| Diabetes Mellitus, Type 1 | 7 |
| Cardiovascular Diseases | 4 |
| Diabetes, Gestational | 4 |
Trials
Showing 1 to 25 of 152. Each trial links to its page on Pharma Observatory.
52 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.